Spatial Genomics and Transcriptomics Market
is anticipated to witness impressive growth during the forecast period. This can be ascribed to
growing demand for early diagnosis and remedial treatment and developing
innovative products for the treatment of chronic diseases. Also, increasing
funding for cell-based research and growing demand for novel cell assays for
cancer research are the major factors for driving the growth of the Global
Spatial Genomics and Transcriptomics Market during the forecast period. In 2020, Cancer Transcriptome Atlas
launched a new product based on Nano String Technologies' and launched a new platform called as GeoMx
Digital Spatial Profiler (DSP) platform, which is used for readout on
Illumina's next-generation sequencing (NGS) technology.
Increasing
Demand for Personalized Medicine
Personalized
medicine is one of the key drivers of the growth of Global Spatial Genomics and
Transcriptomics Market. Personalized medicine involves the use of genomic
information to tailor treatments to individual patients, with the aim of
improving treatment outcomes and reducing adverse effects. Spatial genomics and
transcriptomics provide a more comprehensive understanding of the organization
and function of genes, making it easier to develop personalized treatments for
patients with complex diseases.
Spatial
genomics and transcriptomics can help to identify specific genes and their
expression patterns that are associated with disease, allowing for more
targeted and effective therapies. This can be particularly beneficial for
patients with cancer, as spatial genomics and transcriptomics can help to
identify genetic changes that lead to the development and progression of
cancer. Spatial genomics and
transcriptomics can be used to monitor the response of patients to treatment,
allowing for personalized adjustments to be made to their therapy as needed.
This can help to improve treatment outcomes and reduce the risk of adverse
effects. The growing demand for
personalized medicine is driving the adoption of spatial genomics and
transcriptomics in the biotechnology and pharmaceutical industry, as well as in
academic and research institutions. This is leading to the development of new
applications for the technology, which is expected to further drive the growth
of the global spatial genomics and transcriptomics market in the coming years.
Download Free Sample Report
Growing
Prevalence of Chronic Diseases
Increasing
prevalence of Chronic diseases, such as cancer, cardiovascular disease, and
diabetes, are a major factor which will drive the growth of the Global Spatial
Genomics and Transcriptomics Market during the forecast period. Spatial
genomics and transcriptomics can help in the early detection, diagnosis, and
treatment of chronic diseases, leading to better patient outcomes.
Spatial genomics and transcriptomics enable
researchers to study the organization and function of genes in specific
tissues, such as cancer cells. This allows for the identification of genes and
gene expression patterns that are associated with the development and
progression of chronic diseases. By understanding the molecular mechanisms
underlying these diseases, researchers can develop new treatments and therapies
that are more targeted and effective. Spatial
genomics and transcriptomics can be used to monitor the response of patients to
treatment, allowing for personalized adjustments to be made to their therapy as
needed. This can help to improve treatment outcomes and reduce the risk of
adverse effects. This is leading to increased investment in research and
development, including the adoption of spatial genomics and transcriptomics in
drug discovery and development.
Rising
Investment in Research & Development
Research
& development (R&D) is a crucial factor in driving the growth of the Global
Spatial Genomics and Transcriptomics Market. Advancements in technology, new
product development, and increasing R&D investment are driving the growth
of the market. As new applications of spatial
genomics and transcriptomics are discovered, there is a growing need for new
and improved products and technologies. This is driving the development of new
instruments, software, and consumables for spatial genomics and
transcriptomics. The introduction of new products and technologies is driving
market growth, as companies seek to differentiate themselves from competitors
and gain market share.
In
addition, R&D investment is critical to the continued development of spatial
genomics and transcriptomics. As the technology becomes more widely adopted,
there is a growing need for new and innovative applications, and the
development of new technologies that can further improve the accuracy and
sensitivity of the technology. R&D investment is necessary to address the
challenges facing the market, such as the high cost of instruments and
consumables, and the complexity of data analysis. Government
funding and private investment in R&D are driving the growth of the global
spatial genomics and transcriptomics market. Governments and private investors
are recognizing the potential of the technology and are providing funding for
research, which is accelerating the development of new applications and
technologies.
Advancements
in Sequencing and Microarray Technologies
Sequencing
and microarray technologies are key factors driving the growth of the Global
Spatial Genomics and Transcriptomics Market. Both technologies play a crucial
role in enabling researchers to study the organization and function of genes in
specific tissues. Sequencing technologies, such
as next-generation sequencing (NGS), enable the sequencing of DNA or RNA from
individual cells or tissues, providing a high-resolution view of the
transcriptome or genome. This allows for the identification of genes and gene
expression patterns that are associated with specific tissues, cell types, or
diseases.
Sequencing
technologies are being widely adopted in spatial genomics and transcriptomics
to enable the identification of cell types and cell interactions in complex
tissues, such as the brain, tumor microenvironments, and immune cells.
Microarray technologies, on the other hand, enable the
detection of gene expression patterns in many genes simultaneously. Microarrays
can be used to study gene expression in individual cells or tissues, or in
large-scale experiments to identify biomarkers or gene signatures associated
with specific diseases.
Spatially
resolved microarray technologies, such as the Nanostring nCounter system, allow
simultaneous detection of gene expression in individual cells or small tissue
regions. The adoption of sequencing and
microarray technologies in Spatial Genomics and Transcriptomics is driving the
development of new applications and products, such as spatially resolved
transcriptomics and single-cell sequencing. The availability of these
technologies is driving the growth of the market, as more researchers and
companies can access and utilize the technology.
Increasing
Adoption of Bioinformatics
Bioinformatics
is a crucial factor driving the growth of the Global Spatial Genomics and Transcriptomics
Market. Spatial genomics and transcriptomics generate large volumes of data,
and the analysis and interpretation of this data require advanced computational
tools and algorithms. Bioinformatics provides the necessary tools and
techniques for the analysis and interpretation of spatial genomics and
transcriptomics data. Bioinformatics tools enable
researchers to identify patterns in gene expression and genomic organization in
specific tissues, and to understand the functional relationships between genes
and proteins. These tools also enable the integration of spatial genomics and
transcriptomics data with other types of genomic and proteomic data, enabling a
more comprehensive understanding of gene function and regulation.
The
availability of bioinformatics tools is driving the development of new
applications and products in spatial genomics and transcriptomics. Companies
are developing software platforms and analysis tools that enable researchers to
analyze and visualize spatial genomics and transcriptomics data, and to
integrate this data with other types of genomic and proteomic data. The availability of bioinformatics tools is
driving the growth of the market, as more researchers and companies can access
and utilize the technology. The development of open-source bioinformatics tools
and databases, such as the Allen Brain Atlas, is driving the growth of the
market, as these tools enable researchers to access and analyze spatial
genomics and transcriptomics data from a variety of sources.
Recent Development
- 10x Genomics Visium Spatial Gene Expression Solution:
Launched in 2019, this solution enables the high-throughput analysis of gene
expression and tissue morphology in situ, allowing researchers to understand
the spatial organization of cells and tissues.
- NanoString GeoMx Digital Spatial Profiler: Launched in
2018, this platform provides high-resolution spatial profiling of RNA and
protein expression in tissues, enabling the characterization of complex
cellular environments and the identification of disease biomarkers.
- Cartana Spatial Transcriptomics Kit: Launched in 2020,
this kit enables the capture and analysis of RNA expression data in situ,
allowing researchers to study gene expression patterns within complex tissue
structures.
- Akoya Biosciences Phenoptics 2.0: Launched in 2021,
this imaging platform enables the multiplexed analysis of tissue samples,
combining spatial profiling with phenotypic analysis to provide a more
comprehensive understanding of cellular function.
- Fluidigm Advanta Spatial Transcriptomics: Launched in
2019, this technology allows for the capture and analysis of RNA expression
data in situ, providing high-resolution spatial information about gene
expression patterns in tissues.
Market Segmentation
Global Spatial
Genomics and Transcriptomics market can be segmented by technique, product
type, application, end user, and region. Based on the technique, the market can
be divided into spatial transcriptomics and spatial genomics analysis. Based on
product type, the market can be segmented into instruments, consumables, and
software. Based on application, the market can be divided into Translational
Research and Drug discovery & development. Based on end user, the market
can be differentiated into pharmaceutical & biotechnology companies,
contract research organizations, and academic & research institutes.
Market Players
10X Genomics Inc.,
Akoya Bioscience Ltd., Biospyder Technologies Inc.,
BioTechne Corporation., Dovetail
Genomics LLC., Fluidigm Corporation., Genomic
Vision SA., Illumina Inc., Lunaphore Technologies SA., Nanostring Technolgies Inc. are some of the leading players operating in the Global Spatial
Genomics and Transcriptomics Market.
|
Attribute
|
Details
|
|
Base
Year
|
2022
|
|
Historic
Data
|
2018 –
2021
|
|
Estimated
Year
|
2023
|
|
Forecast
Period
|
2024
– 2028
|
|
Quantitative
Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments
Covered
|
By Technique
By Product Type
By Application
By End User
By Region
|
|
Regional
scope
|
North
America; Europe; Asia Pacific; South America; Middle East & Africa
|
|
Country
scope
|
United States; Canada; Mexico; France; Germany; United
Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina;
Colombia; South Africa; Saudi Arabia; UAE
|
|
Key
companies profiled
|
10X
Genomics Inc., Akoya Bioscience Ltd., Biospyder Technologies Inc., BioTechne
Corporation., Dovetail Genomics LLC., Fluidigm Corporation., Genomic Vision
SA., Illumina Inc., Lunaphore Technologies SA., Nanostring Technolgies Inc
|
|
Customization
scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
|
Pricing
and purchase options
|
Avail
customized purchase options to meet your exact research needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel through
Email (We can also provide the editable version of the report in PPT/Word format
on special request)
|
Report Scope:
In this report, Global Spatial Genomics and
Transcriptomics market has
been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
Spatial Genomics and Transcriptomics Market, By Technique:
o Spatial Transcriptomics
o Spatial Genomics Analysis
Spatial Genomics and Transcriptomics Market, By Product Type:
o Instruments
o Consumables
o Software
Spatial Genomics and Transcriptomics Market, By Application:
o Translational Research
o Drug discovery & development
Spatial Genomics and Transcriptomics Market, By End User:
o Pharmaceutical & Biotechnology companies
o Contract Research Organizations
o Academic & Research Institutes
Spatial Genomics and Transcriptomics Market, By Region:
o North America
- United States
- Canada
- Mexico
o Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
o Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
o South America
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Global Spatial Genomics and
Transcriptomics Market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market
players (up to five).
Global Spatial Genomics and
Transcriptomics Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]